Global Ganja Report

Political space for cannabis is generally on the upswing, but there are some intersecting trends that advocates will need to keep a sharp eye on in the coming year. Corporate cannabis will increase pressure on independent producers, while prohibitionists will try to leverage the vape health scare for anti-cannabis propaganda. And the cannabis industry's own terminology may be actually adding to the confusion.

2019 saw advances for cannabis freedom on both the national and global stage—but also some near-misses, from New York state to Mexico, which have left activists frustrated if no less determined. As advocates prepare to carry the fight into 2020, here's a review of what was achieved—or almost achieved—over the past 12 months.

This year has seen a disturbing nationwide outbreak of lung injuries, some fatal, which researchers link to vaping—either of tobacco products or cannabis concentrates. A regulatory crack-down on the vaping industry has ensued—but amid serious confusion displayed by politicians and media alike.

Having cannabis removed from the federal list of controlled substances has long been the holy grail of legalization advocates. Several bills have now been introduced on Capitol Hill to do exactly that. Do any stand a chance of becoming law in the current polarized climate?

New York's Gov. Cuomo is broaching a cannabis common market for the tri-state area, joining with New Jersey and Connecticut to harmonize regulations and even cooperate in joint purchasing. But the move is being considered partly as a reaction to the vaping scare, and official statements reveal some dangerous confusion as to the distinction between vaping cannabis extracts and smoking actual cannabis.

There has been significant progress toward cannabis legalization in the United States and globally over the past years, but pockets persist of the most repressive and reactionary prohibition. What are the prospects for expanding cannabis freedom in the coming year?

Health authorities have named Vitamin E acetate as a likely suspect in the serious illness that has now affected hundreds across the country after vaping either cannabis or tobacco products. In many of the cases illicit-market dab carts appear to be responsible for the severe pulmonary problems that have now resulted in five deaths. But public authorities and the cannabis industry alike caution that research is ongoing.

Advocates increasingly assert that cannabis legalization is not fully realized unless workers are guaranteed their right to employment even if they partake of the herb off-hours. Some states are finally taking measures to rein in the use of urine-test results as an excuse to fire or turn down job applicants.